Poliscio Analytics LLC
  • Home
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • About
    • About PoliScio
    • Leadership
  • Newsroom
  • Contact
Select Page
Traders, Media Seek FOIA Docs about India Pharma

Traders, Media Seek FOIA Docs about India Pharma

by Randy E. Miller | May 30, 2024 | FDA, FOIA, Hedge Funds, News Media, Pharmaceuticals, Stock Market

FOIAengine: Requests Show FDA Still Under Pressure  This week, we’re taking a closer look at the numerous Freedom of Information Act requests recently filed with the Food and Drug Administration concerning the problematic India pharmaceutical industry. As we noted in...
Forensic FOIA: BLS “Super Users” Are a Case Study

Forensic FOIA: BLS “Super Users” Are a Case Study

by John A. Jenkins | Apr 30, 2024 | FOIA, Hedge Funds, Stock Market

FOIAengine:  Traders Had an Inside Track on the CPI.  Journalists Used FOIA to Expose It. Today’s story is about the Bureau of Labor Statistics, which calculates the all-important Consumer Price Index.  It’s also a cautionary tale about how a select few on Wall Street...
Hot-Button Requests at the FDA as Agency Gets Tough on Menthol Cigarettes

Hot-Button Requests at the FDA as Agency Gets Tough on Menthol Cigarettes

by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market

FOIAengine:  Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
For Elon Musk, a Trail of Legal Challenges

For Elon Musk, a Trail of Legal Challenges

by John A. Jenkins | Mar 6, 2024 | FOIA, Litigation, Short-Selling, Stock Market

FOIAengine Previews an April Fool’s Day Courtrooom Grudge Match This week’s story is about two litigation magnets.  One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk.   The other – Aaron Greenspan –...
Hedge Funds Watching Drug Makers

Hedge Funds Watching Drug Makers

by Randy E. Miller | Feb 14, 2024 | FDA, FOIA, Hedge Funds, Litigation, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas.  That’s according to...
“The Assassin” Strike Again

“The Assassin” Strike Again

by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market

FOIAengine:  Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
« Older Entries
Next Entries »
  • Terms of Service
  • Privacy Policy
Copyright 2025 PoliScio Analytics LLC